AsclepiX Therapeutics

AsclepiX Therapeutics

AsclepiX Therapeutics

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.
Founded
2011
Raised
$35M
Follow us
Latest funding
$35,000,000
Venture capital (Series A) - 2020
Rapha Capital Management Perceptive Xontogeny Venture Fund Perceptive Life Sciences Fund +1
Team Size
1–10
Employees
Pulse 2.0

Biopharmaceutical Company AsclepiX Therapeutics Raises $35 Million

$35,000,000 Venture capital (Series A)
Technical.ly Baltimore

AsclepiX Therapeutics eyeing clinical trials after closing $35M Series A

FinSMEs

AsclepiX Therapeutics Raises $35M in Series A Financing

Xconomy

AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis